Education
About Us
Working with TipRanks
Follow Us
Hookipa Pharma Inc (HOOK)
NASDAQ:HOOK
HOOK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.72 - $6.80
Previous CloseN/A
Volume38.61K
Average Volume (3M)136.51K
Market Cap
$15.92M
Enterprise Value-$53.83M
Total Cash (Recent Filing)$40.28M
Total Debt (Recent Filing)$596.00K
Price to Earnings (P/E)―
Beta2.35
Next Earnings
Aug 07, 2025EPS Estimate
-0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.23
Shares Outstanding9,797,818
10 Day Avg. Volume78,320
30 Day Avg. Volume136,513
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.52
Price to Sales (P/S)0.00
P/FCF Ratio-2.12
Enterprise Value/Market Cap-3.38
Enterprise Value/Revenue-0.35
Enterprise Value/Gross Profit-6.22
Enterprise Value/Ebitda0.27
Forecast
1Y Price Target
$2.00Price Target Upside53.85% Upside
Rating ConsensusHold
Number of Analyst Covering1
Hookipa Pharma News
PremiumCompany Announcements
Hookipa Pharma Sells Assets to Gilead Sciences
PremiumCompany Announcements
Hookipa Pharma Seeks Validation for Stockholder Meetings
Bulls Say, Bears Say
Bulls Say
M&A ActivityPoolbeg shareholders are expected to receive 0.03 shares of Hookipa for each Poolbeg share, resulting in approximately 55% of the equity of the combined entity.
Bears Say
Financial PositionHookipa had approximately $60M in cash, which is believed to be insufficient to support the company to realize meaningful value inflection points from its own pipeline.
Shareholder DilutionCurrent Hookipa shareholders are expected to face significant dilution.
Ownership Overview
2.02% Insiders
6.04% Mutual Funds
33.91% Other Institutional Investors
54.74% Public Companies and Individual Investors
HOOK FAQ
What was Hookipa Pharma Inc’s price range in the past 12 months?
Hookipa Pharma Inc lowest stock price was $0.72 and its highest was $6.80 in the past 12 months.
What is Hookipa Pharma Inc’s market cap?
Hookipa Pharma Inc’s market cap is $15.92M.
When is Hookipa Pharma Inc’s upcoming earnings report date?
Hookipa Pharma Inc’s upcoming earnings report date is Aug 07, 2025 which is in 47 days.
How were Hookipa Pharma Inc’s earnings last quarter?
Hookipa Pharma Inc released its earnings results on May 08, 2025. The company reported -$1.23 earnings per share for the quarter, missing the consensus estimate of -$1.04 by -$0.19.
Is Hookipa Pharma Inc overvalued?
According to Wall Street analysts Hookipa Pharma Inc’s price is currently Undervalued.
Does Hookipa Pharma Inc pay dividends?
Hookipa Pharma Inc does not currently pay dividends.
What is Hookipa Pharma Inc’s EPS estimate?
Hookipa Pharma Inc’s EPS estimate is -0.61.
How many shares outstanding does Hookipa Pharma Inc have?
Hookipa Pharma Inc has 9,797,818 shares outstanding.
What happened to Hookipa Pharma Inc’s price movement after its last earnings report?
Hookipa Pharma Inc reported an EPS of -$1.23 in its last earnings report, missing expectations of -$1.04. Following the earnings report the stock price went down -8.696%.
Which hedge fund is a major shareholder of Hookipa Pharma Inc?
Currently, no hedge funds are holding shares in HOOK
Company Description
Hookipa Pharma Inc
Hookipa Pharma (HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies aimed at preventing and treating infectious diseases and cancers. The company leverages its proprietary arenavirus platform to engineer novel therapies that activate and amplify the immune system's response to target diseases. Hookipa's pipeline includes a range of product candidates designed to address unmet medical needs, with a strategic focus on advancing therapies through clinical trials to demonstrate safety and efficacy.
HOOK Stock 12 Month Forecast
Average Price Target
$2.00
▲(53.85%Upside)